ELIZABETH HEYBOER: Open Payments
NPI 1912936378 · GRAND RAPIDS, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$367 in 3 payments from 3 companies in 2025. Trend: 2023 $155 · 2024 $37 · 2025 $367
Food & beverage: $367
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 1 | $125 |
| Rigel Pharmaceuticals, Inc. | 1 | $125 |
| GENZYME CORPORATION | 1 | $117 |
Products named: IMFINZI, REZLIDHIA, SARCLISA.
Industry payments across MI — which companies pay providers there.
